Pacific Biosciences" Sequel Sees Solid Q2, Competition Rife
Pacific Biosciences (P.....»»
Shake Shack Serves Up Mixed Q1 Results With Strong Sales Growth, Stock Rises
Shake Shack Inc (NYSE:SHAK) sees solid growth with Q1 FY24 sales reaching $290.5 million, though slightly below analyst forecasts. read more.....»»
US Stocks Look Set To Start Week On Solid Note Despite Iran-Israel Conflict, Bitcoin Tops $66K: Why This Analyst Sees Another Tech Bull Run
U.S. stocks m.....»»
US Stocks Look Set To Start Week On Solid Note Despite Iran-Israel Conflict, Bitcoin Tops $66K: Why This Analyst Sees Another Tech Bull Run
U.S. stocks may shake off geopolitical concerns on Monday and aim for a rebound after a week of weakness, as traders eagerly anticipate the upcoming earnings season. read more.....»»
Solid Biosciences price target lowered to $8 from $13 at Barclays
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences expects cash to fund expenditures into 4Q22
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences announces advancement of SGT-003
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences announces IGNITE DMD long term biopsy data update
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences continues patient dosing in IGNITE DMD
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences reports Q1 collaboration revenue $3.3M vs. $0 last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences Provides First Quarter 2021 Business Update and Financial Results
- Patients 7 and 8 dosed in IGNITE-DMD Phase I/II clinical trial under new clinical protocol and second-generation SGT-001 manufacturing process; patient 8 experienced a serious adverse event - - Long-term biopsy data generated from the ongoing I.....»»
EXCLUSIVE: XPeng President Sees Strong EV Growth Trajectory Despite Competition, Supply Chain Issues
After XPeng Inc. read more.....»»
Castle Biosciences sees FY21 revenue $80M-$83M, consensus $79.84M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cellectar Biosciences sees cash runway into 3Q23
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Earnings Results: GoPro stock on a joyride as camera maker sees high-end demand and reaches 1 million subscriptions
GoPro Inc. said Thursday that demand for its more high-end cameras, and an uptick in subscriptions helped boost its first-quarter revenue and get its year off to a "solid start.".....»»
Hudson Pacific Properties sees Q2 FFO ex-items 46c-48c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Union Pacific sees low double digit EPS growth CAGR from 2022-2024
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Union Pacific sees 55% full-year operating ratio in 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Louisiana-Pacific sees Q2 adjusted EBITDA over $580M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pacific Biosciences reports Q1 EPS (45c), consensus (46c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pacific Biosciences options imply 14.3% move in share price post-earnings
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»